It is disclosed a method for the treatment of neurodegenerative disorders, such as ALS, Alzheimers disease, Parkinsons disease, Huntingtons disease and/or retinitis pigmentosa, which method comprises administering to a patient tauroursodeoxycholic acid or a pharmaceutically acceptable salt thereof.